Medical Oncology

The Department of Medical Oncology of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, was the earliest department of medical oncology established in Zhejiang Province and has now developed into a nationally renowned cancer diagnosis and treatment center with strong overall capabilities. The Department of Medical Oncology has a well-structured team of professionals at different levels and is an important training base for medical oncology professionals in Zhejiang Province. Through multilevel and comprehensive collaboration with Mayo Clinic in the United States, the Department of Medical Oncology provides internationally authoritative medical consultation for cancer patients. As one of the earliest institutions in China to carry out radiofrequency ablation for tumors, it has accumulated extensive experience in radiofrequency treatment, particularly for tumors in special and challenging locations such as the lungs and the hepatic dome near the diaphragm. The department has undertaken more than 400 international and domestic multicenter clinical drug studies, providing cancer patients with more professional medical care and more diverse treatment options.

The Department of Medical Oncology has independent research laboratories and a dedicated scientific research team, as well as multiple clinical subspecialty groups and a research platform for mechanisms of tumor drug resistance, providing strong support for the application of translational oncology research results in clinical practice. The department has hosted the "Annual Meeting of the Professional Committee of Tumor Targeted Therapy of the Chinese Anti-Cancer Association" and the "China Conference on Cancer Nutrition and Comprehensive Treatment" and other national conferences on multiple occasions, earning widespread recognition and acclaim within the industry.

Technical Advantages

The Department of Medical Oncology is one of the key specialties of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine. The department has a high-level, specialized medical team with extensive clinical experience and professional expertise. The department has independent outpatient, inpatient, day ward, and intravenous chemotherapy facilities, equipped with advanced medical equipment and technologies, such as PET-CT and ultrasound/CT-guided tumor ablation therapy. The department’s team comprehensively covers the diagnosis and treatment of all cancer types, with a focus on the diagnosis and treatment of respiratory tract tumors, gastrointestinal tumors, gynecologic and breast tumors, genitourinary system tumors, and bone and soft-tissue tumors. At the same time, the department actively promotes and applies modern cancer treatment methods, such as molecular targeted therapy and immunotherapy, to provide patients with more individualized and precise diagnosis and treatment plans.

Academic Status

National Health Commission Specialist Resident Physician Training Base

Chairing Institution of the Expert Committee on Tumor Supportive and Rehabilitation Treatment of the Chinese Society of Clinical Oncology

Chairing Institution of the Expert Committee on Tumor Targeted Therapy of the Chinese Anti-Cancer Association

Zhejiang Provincial Precision Diagnosis Center

Zhejiang Provincial Demonstration Ward for Standardized Cancer Pain Treatment

Zhejiang Provincial Technical Guidance Center for Tumor Targeted Therapy

Research Achievements

The Department of Medical Oncology’s research team primarily conducts scientific research in the areas of tumor pathogenesis, mechanisms of resistance to antitumor drugs and corresponding strategies, immunotherapy, and precise in vivo delivery of antitumor drugs. To date, the Department of Medical Oncology team has led more than 30 National Natural Science Foundation of China projects, 1 National 973 Science and Technology Project, and more than 40 projects from the Zhejiang Provincial Natural Science Foundation, the Zhejiang Provincial Department of Science and Technology, the Department of Human Resources and Social Security, the Department of Health, the Health and Family Planning Commission, the Zhejiang Provincial Qianjiang Talent Program, the Ministry of Education Central Universities projects, and the Research Grants Council of Hong Kong. Team members have published more than 200 SCI papers, with the highest impact factor reaching 41.